BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 17630117)

  • 21. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
    Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
    Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
    Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
    Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
    Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of endometrial intraepithelial neoplasia with WHO endometrial hyperplasia classification system. A comparative study of 150 cases.
    Popat VC; Vora DN; Gadhvi NS; Bhanvadia VM; Madan YG
    Histopathology; 2010 Oct; 57(4):646-8. PubMed ID: 20955392
    [No Abstract]   [Full Text] [Related]  

  • 29. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
    Horn LC; Bilek K; Schnurrbusch U
    Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
    Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
    Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histologic diagnosis of endometrial cancer].
    Kaku T; Kawano Y; Hagiwara T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
    [No Abstract]   [Full Text] [Related]  

  • 32. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
    Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
    Dallenbach-Hellweg G
    Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endometrial hyperplasia and carcinoma in situ].
    Ganchev S; Maĭnkhard K
    Akush Ginekol (Sofiia); 1997; 36(3):47-50. PubMed ID: 9618961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proposed model for endometrial serous carcinogenesis.
    Zheng W; Xiang L; Fadare O; Kong B
    Am J Surg Pathol; 2011 Jan; 35(1):e1-e14. PubMed ID: 21164282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and follow-up of atypical hyperplasia of corpus endometrium--a critical methodological investigation.
    Geppert M; Smyczek-Gargya B; Menton M
    Zentralbl Gynakol; 1993; 115(11):492-4. PubMed ID: 8296494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. My approach to and thoughts on the typing of ovarian carcinomas.
    McCluggage WG
    J Clin Pathol; 2008 Feb; 61(2):152-63. PubMed ID: 17704261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
    Clarke BA; Gilks CB
    J Clin Pathol; 2010 May; 63(5):410-5. PubMed ID: 20418232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.